Skip to search formSkip to main contentSkip to account menu

BCLC Stage B Hepatocellular Carcinoma

Known as: Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma 
Intermediate hepatocellular carcinoma. Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
521Background: Numerous studies have reported on the efficacy of radiotherapy (RT) after incomplete transarterial… 
2020
2020
AIM Transarterial chemoembolization (TACE) is the treatment modality to the intermediate stage, or BCLC stage B hepatocellular… 
2018
2018
Background: To develop a novel scoring system to predict the development of post-operative ascites by analyzing… 
2017
2017
OBJECTIVE Barcelona clinic liver cancer (BCLC) stage B hepatocellular carcinoma (HCC) is a heterogeneous disease group… 
2017
2017
This study aimed to evaluate the feasibility and effectiveness of microwave ablation-assisted liver resection (MW-LR) and clamp… 
2015
2015
AbstractGelatin sponge particles are commonly used in the conventional transarterial chemoembolization (c-TACE) as an adjuvant… 
2015
2015
As a general principle, it is essential to generate, summarize, and understand the best available evidence in order to establish… 
2015
2015
  • 2015
  • Corpus ID: 206172674
This case focused on a 66-year-old woman, who was a hepatitis B carrier with Barcelona Clinic Liver Cancer stage B hepatocellular… 
2012
2012
Objective To investigate prognostic factors affecting the outcomes of patients with Barcelona Clinic Liver Cancer(BCLC) stage B…